data_1fls_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1fls _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.7 m . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.35 -0.611 . . . . 1.3200000000000001 109.35 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.9 mt -86.32 133.35 33.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.258 -0.901 . . . . 1.3100000000000001 109.112 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -159.97 163.54 34.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.286 -0.884 . . . . 2.1400000000000001 109.588 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -71.86 147.64 46.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.18 -0.95 . . . . 0.47999999999999998 109.499 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.421 ' O ' ' OG ' ' A' ' 11' ' ' SER . 0.5 OUTLIER -90.01 6.28 42.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.871 . . . . 1.9199999999999999 109.933 -179.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.4 pttt -145.36 153.47 41.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.241 -0.912 . . . . 1.97 109.634 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.568 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.52 -0.26 57.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.351 -0.843 . . . . 1.3700000000000001 110.298 -179.393 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -99.64 129.71 45.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.277 -0.889 . . . . 1.8100000000000001 109.61 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.0 mt -140.94 150.91 43.73 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.448 -0.782 . . . . 1.0700000000000001 109.422 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.5 p -131.21 156.07 45.99 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.592 -0.693 . . . . 1.05 109.399 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -145.7 159.95 42.41 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.207 -0.933 . . . . 0.84999999999999998 110.26 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.421 ' HE ' ' HA ' ' A' ' 55' ' ' ASP . 23.7 ttt-85 -146.11 133.37 20.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.46 -0.775 . . . . 3.8399999999999999 109.975 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.7 mt -89.76 117.19 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.176 -0.952 . . . . 1.5900000000000001 109.407 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.6 t -70.03 -39.64 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.264 -0.897 . . . . 1.1100000000000001 109.705 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.479 ' OD1' ' N ' ' A' ' 21' ' ' ASN . 16.9 p-10 -155.53 164.57 38.49 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.135 -0.978 . . . . 1.5 109.806 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.581 ' O ' ' O ' ' A' ' 23' ' ' THR . 93.2 m-85 -109.24 5.93 24.19 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.641 -0.662 . . . . 1.3799999999999999 110.639 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.581 ' O ' ' O ' ' A' ' 22' ' ' TYR . 11.4 t 50.39 136.81 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.351 0 CA-C-O 120.757 0.313 . . . . 1.28 110.858 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -69.55 -7.76 21.83 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 CA-C-N 119.545 0.873 . . . . 0.83999999999999997 113.639 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -58.29 -32.97 68.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.946 -1.096 . . . . 1.3400000000000001 109.857 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.7 mtm -140.32 161.62 37.25 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.229 -0.919 . . . . 1.25 109.782 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.3 p -71.46 158.73 35.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.395 -0.815 . . . . 1.1399999999999999 109.267 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.477 ' CD2' ' N ' ' A' ' 28' ' ' HIS . 11.7 m170 -60.03 -40.71 90.28 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.359 -0.838 . . . . 2.7000000000000002 109.968 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.6 m -60.06 -40.21 88.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.024 -1.048 . . . . 0.95999999999999996 110.447 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -69.47 -40.05 77.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.072 -1.017 . . . . 1.5900000000000001 109.932 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.08 -42.03 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 1.0700000000000001 110.324 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.99 -48.81 80.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.13 -0.981 . . . . 1.45 110.545 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -62.77 -33.01 74.27 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.913 -1.117 . . . . 2.1400000000000001 110.177 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.27 -49.41 77.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.866 -1.146 . . . . 1.02 109.806 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -66.23 -40.0 89.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.048 -1.032 . . . . 0.23999999999999999 109.702 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -59.99 -41.63 92.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.979 -1.076 . . . . 2.5099999999999998 109.803 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -60.02 -41.48 92.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.859 -1.151 . . . . 2.3300000000000001 108.872 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.11 -50.01 75.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.477 -0.764 . . . . 1.0600000000000001 109.674 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -63.0 -39.94 96.28 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.121 -0.987 . . . . 0.34000000000000002 108.969 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -60.01 -50.02 75.39 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.287 -0.883 . . . . 2.02 109.565 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.98 -41.97 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.237 -0.914 . . . . 1.1899999999999999 110.491 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.473 ' O ' ' OG1' ' A' ' 46' ' ' THR . 79.1 m95 -77.87 -38.66 45.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.045 -1.034 . . . . 0.39000000000000001 110.032 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.1 p -69.89 -17.79 63.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.252 -0.905 . . . . 0.96999999999999997 110.12 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.02 -39.99 87.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.124 -0.985 . . . . 0.84999999999999998 110.525 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.4 m -116.55 20.9 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.49 -0.756 . . . . 1.1299999999999999 111.252 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.514 ' C ' ' H ' ' A' ' 48' ' ' LEU . 33.7 p -139.29 123.69 11.3 Favored Pre-proline 0 N--CA 1.503 2.19 0 O-C-N 120.977 -1.077 . . . . 1.1499999999999999 108.901 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -67.08 17.68 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.301 0 CA-C-N 120.243 1.122 . . . . 0.41999999999999998 112.233 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.514 ' H ' ' C ' ' A' ' 46' ' ' THR . 50.4 mt -68.56 140.02 55.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.149 -0.969 . . . . 1.1499999999999999 109.102 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -109.79 120.85 43.77 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.956 -0.757 . . . . 1.9399999999999999 108.956 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -106.1 126.88 52.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.547 -0.721 . . . . 0.31 109.486 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.0 m -120.03 130.03 54.52 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.392 0.615 . . . . 1.1299999999999999 109.426 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -83.72 130.11 34.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.348 -0.845 . . . . 3.6000000000000001 109.639 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.9 mt -104.16 131.64 51.25 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.366 -0.834 . . . . 1.1399999999999999 109.661 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.431 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 62.0 m170 -70.03 -39.98 75.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.452 -0.78 . . . . 1.8600000000000001 109.955 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 54' ' ' HIS . 81.3 m-20 -146.12 168.11 21.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.303 -0.873 . . . . 1.28 109.787 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.53 179.92 33.47 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.656 -1.378 . . . . 0.5 109.656 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.0 mt -96.42 135.11 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.488 -1.007 . . . . 1.24 109.43 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.71 163.6 15.23 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.402 0.62 . . . . 1.1100000000000001 109.774 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.97 -49.46 77.59 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.372 -0.83 . . . . 1.2 110.084 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.9 mt -109.29 102.05 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.534 -0.729 . . . . 1.1399999999999999 110.04 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.4 ptm -101.37 133.06 46.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.35 -0.844 . . . . 1.1599999999999999 109.15 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.8 mt -108.92 135.51 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.558 -0.714 . . . . 1.1200000000000001 110.079 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.4 p -150.88 160.25 44.02 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.142 -0.974 . . . . 0.84999999999999998 110.043 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -107.75 123.12 48.06 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.019 -0.734 . . . . 0.46999999999999997 109.019 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.91 -177.87 23.71 Favored Glycine 0 N--CA 1.498 2.794 0 C-N-CA 120.492 -0.861 . . . . 0.46000000000000002 111.029 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.577 ' O ' ' C ' ' A' ' 67' ' ' LYS . 57.2 mt -130.55 160.71 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.787 -0.819 . . . . 1.54 108.787 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.577 ' C ' ' O ' ' A' ' 66' ' ' ILE . 20.9 tptm -11.13 -84.23 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.688 0 CA-C-O 121.072 0.463 . . . . 2.4300000000000002 110.906 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -72.82 133.54 44.51 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.018 -1.104 . . . . 2.4500000000000002 108.018 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.646 ' CG ' ' O ' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -141.78 37.22 1.62 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 122.693 1.235 . . . . 2.54 109.995 -178.554 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.66 46.32 93.49 Favored Glycine 0 N--CA 1.494 2.541 0 O-C-N 121.047 -1.033 . . . . 2.5299999999999998 110.663 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.534 ' OD2' ' CE1' ' A' ' 69' ' ' HIS . 5.6 m-20 -153.95 159.58 41.75 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.099 -1.236 . . . . 4.1600000000000001 109.98 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.504 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -81.37 15.01 2.16 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.662 -0.866 . . . . 4.9199999999999999 108.662 179.27 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -123.66 57.54 12.34 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.843 -0.535 . . . . 5.2199999999999998 110.003 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -53.89 155.74 13.9 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 120.384 0.723 . . . . 1.7 111.125 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.559 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 89.8 m-85 -80.2 160.53 25.59 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.792 -1.188 . . . . 1.0900000000000001 107.792 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 79' ' ' SER . 33.2 p-10 -96.44 19.76 11.62 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.095 -1.003 . . . . 0.54000000000000004 110.525 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.67 -151.91 17.53 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.183 -1.567 . . . . 0.45000000000000001 109.183 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -64.74 -61.33 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.284 0 CA-C-N 118.805 1.302 . . . . 0.87 112.609 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.429 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 52.4 p -77.81 159.99 28.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.105 -0.997 . . . . 0.97999999999999998 109.876 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.78 -130.76 9.39 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.029 -1.228 . . . . 0.37 110.029 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.449 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 8.2 mt -68.56 106.45 2.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -1.119 . . . . 1.1000000000000001 108.842 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 49.5 mt -79.73 -23.53 42.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.058 -1.026 . . . . 1.0700000000000001 109.513 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -176.37 168.77 2.75 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.475 -0.935 . . . . 1.05 108.475 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -161.03 160.24 30.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.997 -1.064 . . . . 2.02 109.685 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.54 167.65 22.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.393 -0.817 . . . . 1.0600000000000001 109.514 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -105.64 152.35 40.05 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 108.739 -0.838 . . . . 1.02 108.739 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -55.98 167.16 2.52 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 120.821 1.014 . . . . 0.72999999999999998 112.597 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -59.06 85.39 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.389 1.392 . . . . 0.88 112.456 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.417 ' H ' ' HA3' ' A' ' 93' ' ' GLY . . . -110.06 -167.26 19.73 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.056 -1.618 . . . . 1.01 109.056 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.404 ' HB2' ' H ' ' A' ' 91' ' ' ASN . 3.5 Cg_exo -65.28 -129.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.321 1.347 . . . . 1.8500000000000001 111.012 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.404 ' H ' ' HB2' ' A' ' 90' ' ' PRO . 39.4 m-20 -64.83 -45.7 85.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.188 -1.57 . . . . 4.2000000000000002 110.979 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -63.35 -40.44 97.29 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.871 -1.143 . . . . 4.9100000000000001 111.322 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.417 ' HA3' ' H ' ' A' ' 89' ' ' GLY . . . -66.61 168.09 36.15 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.77 -1.205 . . . . 0.69999999999999996 110.68 -178.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 69.53 5.07 48.64 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.349 -1.1 . . . . 1.1399999999999999 110.349 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.8 p-10 -79.24 164.23 24.33 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.711 -1.464 . . . . 1.1399999999999999 109.447 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.76 125.83 11.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.102 -0.999 . . . . 1.0800000000000001 109.852 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 52.9 m170 -115.63 149.36 38.43 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.744 -0.598 . . . . 1.24 109.87 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -127.32 151.33 48.9 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.766 -0.584 . . . . 0.31 109.464 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.559 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 35.1 m-20 -79.47 123.22 27.34 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.119 -0.988 . . . . 0.89000000000000001 109.693 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -86.89 -7.52 58.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.17 -0.956 . . . . 1.21 109.298 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -83.87 -10.02 58.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.328 -0.857 . . . . 1.25 109.311 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -92.57 169.97 10.11 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.505 -0.747 . . . . 1.6299999999999999 109.699 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 54.0 m -99.18 105.31 17.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.502 -0.749 . . . . 1.0800000000000001 109.084 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.47 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 93.4 m95 -88.74 124.1 33.8 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.39 -0.819 . . . . 0.35999999999999999 108.801 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.1 t -139.99 157.69 45.26 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.487 -0.758 . . . . 1.0700000000000001 109.907 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.18 -10.16 28.79 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.563 -0.902 . . . . 1.97 108.563 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 54.0 p -91.07 -175.34 4.28 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.748 -0.834 . . . . 1.8200000000000001 108.748 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.496 ' OG ' ' CE2' ' A' ' 143' ' ' TYR . 0.1 OUTLIER -84.77 78.25 9.91 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.967 -1.083 . . . . 2.0 109.234 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 110' ' ' GLY . 76.2 mttt -149.41 151.07 33.42 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.031 -1.043 . . . . 2.3399999999999999 108.678 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 43.91 -140.02 3.56 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.627 -1.389 . . . . 0.26000000000000001 109.627 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -100.02 116.12 31.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.426 -1.044 . . . . 0.94999999999999996 109.309 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -62.32 132.04 51.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.089 -1.007 . . . . 1.8 109.546 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.5 tp -60.04 -43.24 95.47 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.367 -0.833 . . . . 1.05 110.401 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -59.9 -40.95 90.52 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.192 -0.943 . . . . 0.5 111.065 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.77 -49.94 75.78 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.834 -1.166 . . . . 1.1299999999999999 109.28 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 75.1 t -70.0 -41.16 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.164 -0.96 . . . . 1.05 110.293 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.74 -52.48 65.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.003 -1.061 . . . . 1.05 109.754 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.98 -35.3 74.71 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.273 -0.892 . . . . 1.05 109.948 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -64.15 -50.99 66.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.33000000000000002 110.682 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.13 -38.28 82.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.747 -1.221 . . . . 1.6699999999999999 110.064 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -59.99 -40.02 87.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.83 -1.169 . . . . 0.68000000000000005 108.77 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -59.11 -42.0 96.85 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.234 -1.546 . . . . 0.22 109.234 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -67.04 -40.03 87.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.084 -1.245 . . . . 0.46999999999999997 109.112 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 83.6 p -67.4 -24.66 65.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.394 -0.816 . . . . 0.88 109.821 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 39.3 mt -83.01 -0.12 47.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.149 -0.97 . . . . 1.05 110.168 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 93.62 5.37 63.18 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.935 -1.126 . . . . 0.29999999999999999 111.018 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.5 mt -85.6 148.09 26.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.798 -1.413 . . . . 1.1100000000000001 109.627 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 9.5 t70 -101.65 175.54 5.52 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.046 -0.724 . . . . 1.23 109.046 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.52 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 60.3 m80 -60.05 139.28 57.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.093 -1.005 . . . . 0.54000000000000004 109.502 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 36.8 t -101.16 153.02 19.95 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.521 -0.737 . . . . 0.96999999999999997 109.091 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -98.67 1.45 46.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.267 -0.896 . . . . 2.7200000000000002 109.876 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 6.9 t70 -86.16 125.38 68.33 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.965 -1.084 . . . . 1.1499999999999999 108.397 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.66 -17.23 57.67 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 CA-C-N 120.089 1.068 . . . . 0.51000000000000001 113.509 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.447 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -90.33 -5.44 69.81 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.519 -1.324 . . . . 0.37 110.23 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.64 146.94 26.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.084 -1.245 . . . . 1.0700000000000001 109.592 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 138' ' ' PHE . 88.6 mt -69.97 -31.23 68.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.927 . . . . 1.0900000000000001 108.658 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 88.0 mmm -72.67 18.56 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.419 -0.8 . . . . 1.22 110.467 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.468 ' H ' ' C ' ' A' ' 136' ' ' LEU . 15.0 t80 -70.02 129.98 90.3 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.919 -1.113 . . . . 0.44 108.078 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -58.47 -11.75 11.98 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 CA-C-N 119.978 1.028 . . . . 0.44 114.467 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 76.8 mt -111.21 136.66 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.244 -0.91 . . . . 1.0800000000000001 109.605 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.416 ' C ' ' CD1' ' A' ' 141' ' ' TYR . 27.2 t80 -72.51 128.9 37.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.506 -0.746 . . . . 0.90000000000000002 110.144 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.0 t -141.05 142.36 34.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.533 -0.729 . . . . 1.0600000000000001 109.496 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.496 ' CE2' ' OG ' ' A' ' 108' ' ' SER . 68.7 t80 -83.22 142.7 30.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.175 -0.953 . . . . 0.94999999999999996 109.377 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.5 t -140.37 153.96 46.56 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.379 -0.826 . . . . 1.51 109.894 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.82 106.0 1.7 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.976 -1.649 . . . . 0.56999999999999995 108.976 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -77.05 3.52 12.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -1.122 . . . . 3.3900000000000001 110.12 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.9 m -59.74 -49.23 78.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.091 -1.006 . . . . 2.1600000000000001 110.298 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -132.66 23.6 4.32 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.414 -0.804 . . . . 4.3300000000000001 110.137 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -65.94 129.57 40.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.946 -1.096 . . . . 0.72999999999999998 110.523 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 15.7 mtm -133.06 148.58 52.2 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.906 -1.146 . . . . 2.7400000000000002 107.906 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.5 mt -51.12 125.17 23.44 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.004 -1.06 . . . . 1.1699999999999999 109.089 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -65.47 176.71 3.18 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 CA-C-N 120.062 1.058 . . . . 0.44 112.543 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -59.98 -39.99 87.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.442 -0.786 . . . . 1.1399999999999999 109.915 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -54.6 -49.21 70.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.222 -0.924 . . . . 1.1299999999999999 109.757 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -70.06 -39.98 75.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -0.955 . . . . 1.1399999999999999 110.435 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.6 t -61.51 -47.88 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.013 -1.054 . . . . 1.0700000000000001 109.777 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -61.08 -39.96 91.88 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.732 -1.23 . . . . 2.6499999999999999 109.482 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.412 ' O ' ' OG ' ' A' ' 161' ' ' SER . . . -69.77 -54.48 12.08 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.26 -0.971 . . . . 0.25 111.267 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.2 tp -60.73 -40.01 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.739 -1.448 . . . . 1.0600000000000001 109.511 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.551 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.9 mt-30 -67.34 -35.17 78.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.023 -1.048 . . . . 2.46 109.469 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 158' ' ' GLY . 87.1 p -64.91 -26.73 68.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.08 -1.013 . . . . 0.93999999999999995 109.536 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 90.7 mt -89.36 -50.15 6.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.205 -0.934 . . . . 1.1200000000000001 110.254 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -93.44 -9.65 37.78 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.098 -1.002 . . . . 0.98999999999999999 109.975 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.492 2.394 0 N-CA-C 109.563 -1.415 . . . . 1.01 109.563 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' WAY . . . . . 0.683 ' HE2' ' C27' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.7 m . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.35 -0.611 . . . . 0.83 109.35 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.9 mt -86.32 133.35 33.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.258 -0.901 . . . . 0.74 109.112 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -159.97 163.54 34.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.286 -0.884 . . . . 1.61 109.588 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -71.86 147.64 46.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.18 -0.95 . . . . 0.48 109.499 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.421 ' O ' ' OG ' ' A' ' 11' ' ' SER . 0.5 OUTLIER -90.01 6.28 42.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.871 . . . . 1.39 109.933 -179.683 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.4 pttt -145.36 153.47 41.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.241 -0.912 . . . . 1.39 109.634 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.568 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.52 -0.26 57.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.351 -0.843 . . . . 1.22 110.298 -179.393 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -99.64 129.71 45.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.277 -0.889 . . . . 1.16 109.61 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 15' ' ' LEU . 96.0 mt -140.94 150.91 43.73 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.448 -0.782 . . . . 0.21 109.422 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.5 p -131.21 156.07 45.99 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.592 -0.693 . . . . 0.26 109.399 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -145.7 159.95 42.41 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.207 -0.933 . . . . 0.39 110.26 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.496 ' HE ' ' HA ' ' A' ' 55' ' ' ASP . 23.7 ttt-85 -146.11 133.37 20.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.46 -0.775 . . . . 3.18 109.975 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.7 mt -89.76 117.19 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.176 -0.952 . . . . 0.93 109.407 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.6 t -70.03 -39.64 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.264 -0.897 . . . . 0.33 109.705 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.479 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 16.9 p-10 -155.53 164.57 38.49 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.135 -0.978 . . . . 1.01 109.806 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.581 ' O ' ' O ' ' A' ' 23' ' ' THR . 93.2 m-85 -109.24 5.93 24.19 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.641 -0.662 . . . . 1.38 110.639 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.581 ' O ' ' O ' ' A' ' 22' ' ' TYR . 11.4 t 50.39 136.81 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.351 0 CA-C-O 120.757 0.313 . . . . 0.86 110.858 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -69.55 -7.76 21.83 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 CA-C-N 119.545 0.873 . . . . 0.66 113.639 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -58.29 -32.97 68.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.946 -1.096 . . . . 1.34 109.857 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.7 mtm -140.32 161.62 37.25 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.229 -0.919 . . . . 0.89 109.782 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.3 p -71.46 158.73 35.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.395 -0.815 . . . . 0.51 109.267 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -60.03 -40.71 90.28 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.359 -0.838 . . . . 1.95 109.968 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.6 m -60.06 -40.21 88.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.024 -1.048 . . . . 0.45 110.447 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -69.47 -40.05 77.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.072 -1.017 . . . . 1.59 109.932 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.08 -42.03 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.24 110.324 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.99 -48.81 80.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.13 -0.981 . . . . 1.45 110.545 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -62.77 -33.01 74.27 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.913 -1.117 . . . . 1.6 110.177 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.27 -49.41 77.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.866 -1.146 . . . . 0.17 109.806 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.528 ' CE1' HD13 ' A' ' 62' ' ' ILE . 52.8 m-85 -66.23 -40.0 89.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.048 -1.032 . . . . 0.22 109.702 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -59.99 -41.63 92.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.979 -1.076 . . . . 1.99 109.803 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -60.02 -41.48 92.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.859 -1.151 . . . . 1.77 108.872 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.11 -50.01 75.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.477 -0.764 . . . . 0.19 109.674 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -63.0 -39.94 96.28 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.121 -0.987 . . . . 0.28 108.969 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -60.01 -50.02 75.39 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.287 -0.883 . . . . 1.4 109.565 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.98 -41.97 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.237 -0.914 . . . . 0.44 110.491 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -77.87 -38.66 45.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.045 -1.034 . . . . 0.31 110.032 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.1 p -69.89 -17.79 63.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.252 -0.905 . . . . 0.21 110.12 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.02 -39.99 87.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.124 -0.985 . . . . 0.85 110.525 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.4 m -116.55 20.9 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.49 -0.756 . . . . 0.64 111.252 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.476 ' C ' ' H ' ' A' ' 48' ' ' LEU . 33.7 p -139.29 123.69 11.3 Favored Pre-proline 0 N--CA 1.503 2.19 0 O-C-N 120.977 -1.077 . . . . 0.43 108.901 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -67.08 17.68 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.301 0 CA-C-N 120.243 1.122 . . . . 0.35 112.233 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.476 ' H ' ' C ' ' A' ' 46' ' ' THR . 50.4 mt -68.56 140.02 55.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.149 -0.969 . . . . 0.41 109.102 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -109.79 120.85 43.77 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.956 -0.757 . . . . 1.14 108.956 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -106.1 126.88 52.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.547 -0.721 . . . . 0.31 109.486 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.0 m -120.03 130.03 54.52 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.392 0.615 . . . . 0.35 109.426 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -83.72 130.11 34.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.348 -0.845 . . . . 3.05 109.639 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.9 mt -104.16 131.64 51.25 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.366 -0.834 . . . . 0.36 109.661 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.431 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 62.0 m170 -70.03 -39.98 75.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.452 -0.78 . . . . 1.35 109.955 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.496 ' HA ' ' HE ' ' A' ' 18' ' ' ARG . 81.3 m-20 -146.12 168.11 21.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.303 -0.873 . . . . 1.28 109.787 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.53 179.92 33.47 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.656 -1.378 . . . . 0.46 109.656 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.0 mt -96.42 135.11 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.488 -1.007 . . . . 0.56 109.43 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.71 163.6 15.23 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.402 0.62 . . . . 0.27 109.774 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.97 -49.46 77.59 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.372 -0.83 . . . . 1.2 110.084 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.9 mt -109.29 102.05 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.534 -0.729 . . . . 0.39 110.04 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.4 ptm -101.37 133.06 46.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.35 -0.844 . . . . 0.54 109.15 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.528 HD13 ' CE1' ' A' ' 35' ' ' PHE . 85.8 mt -108.92 135.51 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.558 -0.714 . . . . 0.3 110.079 -178.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.4 p -150.88 160.25 44.02 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.142 -0.974 . . . . 0.25 110.043 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -107.75 123.12 48.06 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.019 -0.734 . . . . 0.4 109.019 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.91 -177.87 23.71 Favored Glycine 0 N--CA 1.498 2.794 0 C-N-CA 120.492 -0.861 . . . . 0.4 111.029 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.577 ' O ' ' C ' ' A' ' 67' ' ' LYS . 57.2 mt -130.55 160.71 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.787 -0.819 . . . . 0.93 108.787 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.577 ' C ' ' O ' ' A' ' 66' ' ' ILE . 20.9 tptm -11.13 -84.23 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.688 0 CA-C-O 121.072 0.463 . . . . 1.93 110.906 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -72.82 133.54 44.51 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.018 -1.104 . . . . 2.45 108.018 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.646 ' CG ' ' O ' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -141.78 37.22 1.62 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 122.693 1.235 . . . . 1.81 109.995 -178.554 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.66 46.32 93.49 Favored Glycine 0 N--CA 1.494 2.541 0 O-C-N 121.047 -1.033 . . . . 2.53 110.663 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.534 ' OD2' ' CE1' ' A' ' 69' ' ' HIS . 5.6 m-20 -153.95 159.58 41.75 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.099 -1.236 . . . . 4.16 109.98 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.504 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -81.37 15.01 2.16 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.662 -0.866 . . . . 4.08 108.662 179.27 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -123.66 57.54 12.34 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.843 -0.535 . . . . 5.0 110.003 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -53.89 155.74 13.9 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 120.384 0.723 . . . . 1.35 111.125 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.559 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 89.8 m-85 -80.2 160.53 25.59 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.792 -1.188 . . . . 0.85 107.792 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 79' ' ' SER . 33.2 p-10 -96.44 19.76 11.62 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.095 -1.003 . . . . 0.54 110.525 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.67 -151.91 17.53 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.183 -1.567 . . . . 0.38 109.183 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -64.74 -61.33 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.284 0 CA-C-N 118.805 1.302 . . . . 0.64 112.609 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.429 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 52.4 p -77.81 159.99 28.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.105 -0.997 . . . . 0.38 109.876 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.78 -130.76 9.39 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.029 -1.228 . . . . 0.31 110.029 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.449 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 8.2 mt -68.56 106.45 2.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -1.119 . . . . 0.33 108.842 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.426 HD23 ' OE2' ' A' ' 102' ' ' GLU . 49.5 mt -79.73 -23.53 42.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.058 -1.026 . . . . 0.23 109.513 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -176.37 168.77 2.75 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.475 -0.935 . . . . 0.36 108.475 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -161.03 160.24 30.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.997 -1.064 . . . . 1.32 109.685 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.54 167.65 22.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.393 -0.817 . . . . 0.33 109.514 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -105.64 152.35 40.05 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 108.739 -0.838 . . . . 0.74 108.739 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -55.98 167.16 2.52 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 120.821 1.014 . . . . 0.6 112.597 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -59.06 85.39 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.389 1.392 . . . . 0.88 112.456 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.515 ' H ' ' HA3' ' A' ' 93' ' ' GLY . . . -110.06 -167.26 19.73 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.056 -1.618 . . . . 0.84 109.056 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -65.28 -129.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.321 1.347 . . . . 1.55 111.012 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.4 m-20 -64.83 -45.7 85.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.188 -1.57 . . . . 3.47 110.979 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -63.35 -40.44 97.29 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.871 -1.143 . . . . 4.57 111.322 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.515 ' HA3' ' H ' ' A' ' 89' ' ' GLY . . . -66.61 168.09 36.15 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.77 -1.205 . . . . 0.64 110.68 -178.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 69.53 5.07 48.64 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.349 -1.1 . . . . 1.14 110.349 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.8 p-10 -79.24 164.23 24.33 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.711 -1.464 . . . . 1.14 109.447 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.76 125.83 11.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.102 -0.999 . . . . 0.3 109.852 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 52.9 m170 -115.63 149.36 38.43 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.744 -0.598 . . . . 0.86 109.87 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -127.32 151.33 48.9 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.766 -0.584 . . . . 0.26 109.464 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.559 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 35.1 m-20 -79.47 123.22 27.34 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.119 -0.988 . . . . 0.89 109.693 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -86.89 -7.52 58.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.17 -0.956 . . . . 1.21 109.298 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -83.87 -10.02 58.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.328 -0.857 . . . . 1.25 109.311 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.426 ' OE2' HD23 ' A' ' 82' ' ' LEU . 97.9 mt-10 -92.57 169.97 10.11 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.505 -0.747 . . . . 1.63 109.699 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 54.0 m -99.18 105.31 17.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.502 -0.749 . . . . 0.29 109.084 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.47 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 93.4 m95 -88.74 124.1 33.8 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.39 -0.819 . . . . 0.31 108.801 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.656 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.1 t -139.99 157.69 45.26 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.487 -0.758 . . . . 0.24 109.907 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.18 -10.16 28.79 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.563 -0.902 . . . . 1.44 108.563 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 54.0 p -91.07 -175.34 4.28 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.748 -0.834 . . . . 1.29 108.748 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.496 ' OG ' ' CE2' ' A' ' 143' ' ' TYR . 0.1 OUTLIER -84.77 78.25 9.91 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.967 -1.083 . . . . 1.47 109.234 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.656 ' HB2' HG21 ' A' ' 105' ' ' THR . 76.2 mttt -149.41 151.07 33.42 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.031 -1.043 . . . . 1.79 108.678 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 43.91 -140.02 3.56 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.627 -1.389 . . . . 0.23 109.627 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -100.02 116.12 31.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.426 -1.044 . . . . 0.23 109.309 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -62.32 132.04 51.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.089 -1.007 . . . . 1.06 109.546 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.5 tp -60.04 -43.24 95.47 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.367 -0.833 . . . . 0.2 110.401 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -59.9 -40.95 90.52 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.192 -0.943 . . . . 0.39 111.065 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.77 -49.94 75.78 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.834 -1.166 . . . . 0.36 109.28 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 75.1 t -70.0 -41.16 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.164 -0.96 . . . . 0.22 110.293 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.74 -52.48 65.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.003 -1.061 . . . . 0.19 109.754 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.98 -35.3 74.71 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.273 -0.892 . . . . 0.18 109.948 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -64.15 -50.99 66.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.27 110.682 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.13 -38.28 82.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.747 -1.221 . . . . 1.67 110.064 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -59.99 -40.02 87.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.83 -1.169 . . . . 0.49 108.77 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -59.11 -42.0 96.85 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.234 -1.546 . . . . 0.22 109.234 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -67.04 -40.03 87.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.084 -1.245 . . . . 0.38 109.112 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 83.6 p -67.4 -24.66 65.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.394 -0.816 . . . . 0.27 109.821 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 39.3 mt -83.01 -0.12 47.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.149 -0.97 . . . . 0.33 110.168 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 93.62 5.37 63.18 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.935 -1.126 . . . . 0.3 111.018 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.5 mt -85.6 148.09 26.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.798 -1.413 . . . . 0.32 109.627 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 9.5 t70 -101.65 175.54 5.52 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.046 -0.724 . . . . 1.23 109.046 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.52 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 60.3 m80 -60.05 139.28 57.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.093 -1.005 . . . . 0.35 109.502 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 36.8 t -101.16 153.02 19.95 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.521 -0.737 . . . . 0.4 109.091 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -98.67 1.45 46.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.267 -0.896 . . . . 2.23 109.876 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 6.9 t70 -86.16 125.38 68.33 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.965 -1.084 . . . . 1.15 108.397 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.66 -17.23 57.67 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 CA-C-N 120.089 1.068 . . . . 0.42 113.509 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -90.33 -5.44 69.81 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.519 -1.324 . . . . 0.34 110.23 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.64 146.94 26.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.084 -1.245 . . . . 0.27 109.592 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.425 ' C ' ' H ' ' A' ' 138' ' ' PHE . 88.6 mt -69.97 -31.23 68.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.927 . . . . 0.32 108.658 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 88.0 mmm -72.67 18.56 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.419 -0.8 . . . . 0.83 110.467 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.425 ' H ' ' C ' ' A' ' 136' ' ' LEU . 15.0 t80 -70.02 129.98 90.3 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.919 -1.113 . . . . 0.39 108.078 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -58.47 -11.75 11.98 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 CA-C-N 119.978 1.028 . . . . 0.44 114.467 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 76.8 mt -111.21 136.66 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.244 -0.91 . . . . 0.3 109.605 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.416 ' CD1' ' C ' ' A' ' 141' ' ' TYR . 27.2 t80 -72.51 128.9 37.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.506 -0.746 . . . . 0.33 110.144 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.0 t -141.05 142.36 34.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.533 -0.729 . . . . 0.29 109.496 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.496 ' CE2' ' OG ' ' A' ' 108' ' ' SER . 68.7 t80 -83.22 142.7 30.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.175 -0.953 . . . . 0.31 109.377 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.5 t -140.37 153.96 46.56 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.379 -0.826 . . . . 1.0 109.894 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.82 106.0 1.7 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.976 -1.649 . . . . 0.53 108.976 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -77.05 3.52 12.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -1.122 . . . . 2.91 110.12 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.9 m -59.74 -49.23 78.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.091 -1.006 . . . . 1.71 110.298 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -132.66 23.6 4.32 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.414 -0.804 . . . . 3.55 110.137 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -65.94 129.57 40.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.946 -1.096 . . . . 0.57 110.523 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 15.7 mtm -133.06 148.58 52.2 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.906 -1.146 . . . . 2.23 107.906 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.5 mt -51.12 125.17 23.44 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.004 -1.06 . . . . 0.46 109.089 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -65.47 176.71 3.18 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 CA-C-N 120.062 1.058 . . . . 0.32 112.543 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -59.98 -39.99 87.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.442 -0.786 . . . . 1.14 109.915 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -54.6 -49.21 70.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.222 -0.924 . . . . 1.13 109.757 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -70.06 -39.98 75.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -0.955 . . . . 1.14 110.435 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.6 t -61.51 -47.88 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.013 -1.054 . . . . 0.27 109.777 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -61.08 -39.96 91.88 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.732 -1.23 . . . . 1.96 109.482 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.77 -54.48 12.08 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.26 -0.971 . . . . 0.22 111.267 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.446 HG23 ' N ' ' A' ' 160' ' ' GLN . 4.2 tp -60.73 -40.01 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.739 -1.448 . . . . 0.27 109.511 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.551 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.9 mt-30 -67.34 -35.17 78.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.023 -1.048 . . . . 1.88 109.469 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 87.1 p -64.91 -26.73 68.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.08 -1.013 . . . . 0.35 109.536 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 90.7 mt -89.36 -50.15 6.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.205 -0.934 . . . . 0.36 110.254 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -93.44 -9.65 37.78 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.098 -1.002 . . . . 0.43 109.975 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.492 2.394 0 N-CA-C 109.563 -1.415 . . . . 1.01 109.563 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 169' ' ' WAY . . . . . 1.087 ' CJ ' ' HE3' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.7 m . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.35 -0.611 . . . . 0.83 109.35 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.9 mt -86.32 133.35 33.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.258 -0.901 . . . . 0.74 109.112 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -159.97 163.54 34.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.286 -0.884 . . . . 1.61 109.588 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -71.86 147.64 46.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.18 -0.95 . . . . 0.48 109.499 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.421 ' O ' ' OG ' ' A' ' 11' ' ' SER . 0.5 OUTLIER -90.01 6.28 42.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.871 . . . . 1.39 109.933 -179.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.4 pttt -145.36 153.47 41.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.241 -0.912 . . . . 1.39 109.634 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.568 ' N ' ' SD ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -90.52 -0.26 57.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.351 -0.843 . . . . 1.22 110.298 -179.393 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -99.64 129.71 45.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.277 -0.889 . . . . 1.16 109.61 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 15' ' ' LEU . 96.0 mt -140.94 150.91 43.73 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.448 -0.782 . . . . 0.21 109.422 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.5 p -131.21 156.07 45.99 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.592 -0.693 . . . . 0.26 109.399 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -145.7 159.95 42.41 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.207 -0.933 . . . . 0.39 110.26 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.496 ' HE ' ' HA ' ' A' ' 55' ' ' ASP . 23.7 ttt-85 -146.11 133.37 20.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.46 -0.775 . . . . 3.18 109.975 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.7 mt -89.76 117.19 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.176 -0.952 . . . . 0.93 109.407 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.6 t -70.03 -39.64 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.264 -0.897 . . . . 0.33 109.705 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.479 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 16.9 p-10 -155.53 164.57 38.49 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.135 -0.978 . . . . 1.01 109.806 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.581 ' O ' ' O ' ' A' ' 23' ' ' THR . 93.2 m-85 -109.24 5.93 24.19 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.641 -0.662 . . . . 1.38 110.639 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.581 ' O ' ' O ' ' A' ' 22' ' ' TYR . 11.4 t 50.39 136.81 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.351 0 CA-C-O 120.757 0.313 . . . . 0.86 110.858 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -69.55 -7.76 21.83 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 CA-C-N 119.545 0.873 . . . . 0.66 113.639 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -58.29 -32.97 68.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.946 -1.096 . . . . 1.34 109.857 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 78.7 mtm -140.32 161.62 37.25 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.229 -0.919 . . . . 0.89 109.782 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.3 p -71.46 158.73 35.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.395 -0.815 . . . . 0.51 109.267 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.477 ' N ' ' CD2' ' A' ' 28' ' ' HIS . 11.7 m170 -60.03 -40.71 90.28 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.359 -0.838 . . . . 1.95 109.968 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.6 m -60.06 -40.21 88.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.024 -1.048 . . . . 0.45 110.447 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -69.47 -40.05 77.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.072 -1.017 . . . . 1.59 109.932 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.08 -42.03 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.24 110.324 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.99 -48.81 80.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.13 -0.981 . . . . 1.45 110.545 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -62.77 -33.01 74.27 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.913 -1.117 . . . . 1.6 110.177 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.27 -49.41 77.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.866 -1.146 . . . . 0.17 109.806 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.528 ' CE1' HD13 ' A' ' 62' ' ' ILE . 52.8 m-85 -66.23 -40.0 89.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.048 -1.032 . . . . 0.22 109.702 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -59.99 -41.63 92.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.979 -1.076 . . . . 1.99 109.803 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -60.02 -41.48 92.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.859 -1.151 . . . . 1.77 108.872 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.11 -50.01 75.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.477 -0.764 . . . . 0.19 109.674 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -63.0 -39.94 96.28 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.121 -0.987 . . . . 0.28 108.969 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -60.01 -50.02 75.39 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.287 -0.883 . . . . 1.4 109.565 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.98 -41.97 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.237 -0.914 . . . . 0.44 110.491 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -77.87 -38.66 45.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.045 -1.034 . . . . 0.31 110.032 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.1 p -69.89 -17.79 63.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.252 -0.905 . . . . 0.21 110.12 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.02 -39.99 87.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.124 -0.985 . . . . 0.85 110.525 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.4 m -116.55 20.9 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.49 -0.756 . . . . 0.64 111.252 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.476 ' C ' ' H ' ' A' ' 48' ' ' LEU . 33.7 p -139.29 123.69 11.3 Favored Pre-proline 0 N--CA 1.503 2.19 0 O-C-N 120.977 -1.077 . . . . 0.43 108.901 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -67.08 17.68 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.301 0 CA-C-N 120.243 1.122 . . . . 0.35 112.233 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.476 ' H ' ' C ' ' A' ' 46' ' ' THR . 50.4 mt -68.56 140.02 55.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.149 -0.969 . . . . 0.41 109.102 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -109.79 120.85 43.77 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.956 -0.757 . . . . 1.14 108.956 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -106.1 126.88 52.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.547 -0.721 . . . . 0.31 109.486 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.0 m -120.03 130.03 54.52 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.392 0.615 . . . . 0.35 109.426 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -83.72 130.11 34.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.348 -0.845 . . . . 3.05 109.639 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.9 mt -104.16 131.64 51.25 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.366 -0.834 . . . . 0.36 109.661 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.431 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 62.0 m170 -70.03 -39.98 75.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.452 -0.78 . . . . 1.35 109.955 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.496 ' HA ' ' HE ' ' A' ' 18' ' ' ARG . 81.3 m-20 -146.12 168.11 21.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.303 -0.873 . . . . 1.28 109.787 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.53 179.92 33.47 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.656 -1.378 . . . . 0.46 109.656 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.0 mt -96.42 135.11 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.488 -1.007 . . . . 0.56 109.43 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.71 163.6 15.23 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.402 0.62 . . . . 0.27 109.774 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.97 -49.46 77.59 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.372 -0.83 . . . . 1.2 110.084 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.9 mt -109.29 102.05 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.534 -0.729 . . . . 0.39 110.04 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.4 ptm -101.37 133.06 46.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.35 -0.844 . . . . 0.54 109.15 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.528 HD13 ' CE1' ' A' ' 35' ' ' PHE . 85.8 mt -108.92 135.51 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.558 -0.714 . . . . 0.3 110.079 -178.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.4 p -150.88 160.25 44.02 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.142 -0.974 . . . . 0.25 110.043 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -107.75 123.12 48.06 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.019 -0.734 . . . . 0.4 109.019 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.91 -177.87 23.71 Favored Glycine 0 N--CA 1.498 2.794 0 C-N-CA 120.492 -0.861 . . . . 0.4 111.029 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.577 ' O ' ' C ' ' A' ' 67' ' ' LYS . 57.2 mt -130.55 160.71 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.787 -0.819 . . . . 0.93 108.787 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.577 ' C ' ' O ' ' A' ' 66' ' ' ILE . 20.9 tptm -11.13 -84.23 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.688 0 CA-C-O 121.072 0.463 . . . . 1.93 110.906 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -72.82 133.54 44.51 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.018 -1.104 . . . . 2.45 108.018 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.646 ' CG ' ' O ' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -141.78 37.22 1.62 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 122.693 1.235 . . . . 1.81 109.995 -178.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.66 46.32 93.49 Favored Glycine 0 N--CA 1.494 2.541 0 O-C-N 121.047 -1.033 . . . . 2.53 110.663 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.534 ' OD2' ' CE1' ' A' ' 69' ' ' HIS . 5.6 m-20 -153.95 159.58 41.75 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.099 -1.236 . . . . 4.16 109.98 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.504 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -81.37 15.01 2.16 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.662 -0.866 . . . . 4.08 108.662 179.27 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -123.66 57.54 12.34 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.843 -0.535 . . . . 5.0 110.003 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -53.89 155.74 13.9 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 120.384 0.723 . . . . 1.35 111.125 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.559 ' CE1' ' OD1' ' A' ' 99' ' ' ASP . 89.8 m-85 -80.2 160.53 25.59 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.792 -1.188 . . . . 0.85 107.792 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 79' ' ' SER . 33.2 p-10 -96.44 19.76 11.62 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.095 -1.003 . . . . 0.54 110.525 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.67 -151.91 17.53 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.183 -1.567 . . . . 0.38 109.183 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -64.74 -61.33 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.284 0 CA-C-N 118.805 1.302 . . . . 0.64 112.609 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.429 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 52.4 p -77.81 159.99 28.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.105 -0.997 . . . . 0.38 109.876 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.78 -130.76 9.39 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 110.029 -1.228 . . . . 0.31 110.029 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.449 ' O ' ' OD2' ' A' ' 99' ' ' ASP . 8.2 mt -68.56 106.45 2.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -1.119 . . . . 0.33 108.842 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.426 HD23 ' OE2' ' A' ' 102' ' ' GLU . 49.5 mt -79.73 -23.53 42.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.058 -1.026 . . . . 0.23 109.513 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -176.37 168.77 2.75 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.475 -0.935 . . . . 0.36 108.475 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -161.03 160.24 30.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.997 -1.064 . . . . 1.32 109.685 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.54 167.65 22.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.393 -0.817 . . . . 0.33 109.514 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -105.64 152.35 40.05 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 108.739 -0.838 . . . . 0.74 108.739 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -55.98 167.16 2.52 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 120.821 1.014 . . . . 0.6 112.597 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -59.06 85.39 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.389 1.392 . . . . 0.88 112.456 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.515 ' H ' ' HA3' ' A' ' 93' ' ' GLY . . . -110.06 -167.26 19.73 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.056 -1.618 . . . . 0.84 109.056 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -65.28 -129.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.321 1.347 . . . . 1.55 111.012 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.4 m-20 -64.83 -45.7 85.07 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.188 -1.57 . . . . 3.47 110.979 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -63.35 -40.44 97.29 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.871 -1.143 . . . . 4.57 111.322 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.515 ' HA3' ' H ' ' A' ' 89' ' ' GLY . . . -66.61 168.09 36.15 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.77 -1.205 . . . . 0.64 110.68 -178.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 69.53 5.07 48.64 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.349 -1.1 . . . . 1.14 110.349 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.8 p-10 -79.24 164.23 24.33 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.711 -1.464 . . . . 1.14 109.447 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -148.76 125.83 11.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.102 -0.999 . . . . 0.3 109.852 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 52.9 m170 -115.63 149.36 38.43 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.744 -0.598 . . . . 0.86 109.87 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -127.32 151.33 48.9 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.766 -0.584 . . . . 0.26 109.464 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.559 ' OD1' ' CE1' ' A' ' 75' ' ' PHE . 35.1 m-20 -79.47 123.22 27.34 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.119 -0.988 . . . . 0.89 109.693 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -86.89 -7.52 58.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.17 -0.956 . . . . 1.21 109.298 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -83.87 -10.02 58.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.328 -0.857 . . . . 1.25 109.311 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.426 ' OE2' HD23 ' A' ' 82' ' ' LEU . 97.9 mt-10 -92.57 169.97 10.11 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.505 -0.747 . . . . 1.63 109.699 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 54.0 m -99.18 105.31 17.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.502 -0.749 . . . . 0.29 109.084 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.47 ' NE1' ' O ' ' A' ' 99' ' ' ASP . 93.4 m95 -88.74 124.1 33.8 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.39 -0.819 . . . . 0.31 108.801 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.656 HG21 ' HB2' ' A' ' 109' ' ' LYS . 8.1 t -139.99 157.69 45.26 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.487 -0.758 . . . . 0.24 109.907 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.18 -10.16 28.79 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.563 -0.902 . . . . 1.44 108.563 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 54.0 p -91.07 -175.34 4.28 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.748 -0.834 . . . . 1.29 108.748 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.496 ' OG ' ' CE2' ' A' ' 143' ' ' TYR . 0.1 OUTLIER -84.77 78.25 9.91 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.967 -1.083 . . . . 1.47 109.234 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.656 ' HB2' HG21 ' A' ' 105' ' ' THR . 76.2 mttt -149.41 151.07 33.42 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.031 -1.043 . . . . 1.79 108.678 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 109' ' ' LYS . . . 43.91 -140.02 3.56 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.627 -1.389 . . . . 0.23 109.627 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -100.02 116.12 31.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.426 -1.044 . . . . 0.23 109.309 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -62.32 132.04 51.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.089 -1.007 . . . . 1.06 109.546 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.5 tp -60.04 -43.24 95.47 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.367 -0.833 . . . . 0.2 110.401 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -59.9 -40.95 90.52 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.192 -0.943 . . . . 0.39 111.065 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.77 -49.94 75.78 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.834 -1.166 . . . . 0.36 109.28 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 75.1 t -70.0 -41.16 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.164 -0.96 . . . . 0.22 110.293 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.74 -52.48 65.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.003 -1.061 . . . . 0.19 109.754 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.98 -35.3 74.71 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.273 -0.892 . . . . 0.18 109.948 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -64.15 -50.99 66.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.27 110.682 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.13 -38.28 82.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.747 -1.221 . . . . 1.67 110.064 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -59.99 -40.02 87.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.83 -1.169 . . . . 0.49 108.77 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -59.11 -42.0 96.85 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.234 -1.546 . . . . 0.22 109.234 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -67.04 -40.03 87.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.084 -1.245 . . . . 0.38 109.112 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 83.6 p -67.4 -24.66 65.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.394 -0.816 . . . . 0.27 109.821 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 39.3 mt -83.01 -0.12 47.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.149 -0.97 . . . . 0.33 110.168 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 93.62 5.37 63.18 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.935 -1.126 . . . . 0.3 111.018 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.5 mt -85.6 148.09 26.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.798 -1.413 . . . . 0.32 109.627 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 129' ' ' HIS . 9.5 t70 -101.65 175.54 5.52 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.046 -0.724 . . . . 1.23 109.046 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.52 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 60.3 m80 -60.05 139.28 57.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.093 -1.005 . . . . 0.35 109.502 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 36.8 t -101.16 153.02 19.95 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.521 -0.737 . . . . 0.4 109.091 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -98.67 1.45 46.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.267 -0.896 . . . . 2.23 109.876 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 6.9 t70 -86.16 125.38 68.33 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.965 -1.084 . . . . 1.15 108.397 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.66 -17.23 57.67 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 CA-C-N 120.089 1.068 . . . . 0.42 113.509 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 132' ' ' ASP . . . -90.33 -5.44 69.81 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.519 -1.324 . . . . 0.34 110.23 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.64 146.94 26.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.084 -1.245 . . . . 0.27 109.592 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.425 ' C ' ' H ' ' A' ' 138' ' ' PHE . 88.6 mt -69.97 -31.23 68.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.927 . . . . 0.32 108.658 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 88.0 mmm -72.67 18.56 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.419 -0.8 . . . . 0.83 110.467 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.425 ' H ' ' C ' ' A' ' 136' ' ' LEU . 15.0 t80 -70.02 129.98 90.3 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.919 -1.113 . . . . 0.39 108.078 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -58.47 -11.75 11.98 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 CA-C-N 119.978 1.028 . . . . 0.44 114.467 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 76.8 mt -111.21 136.66 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.244 -0.91 . . . . 0.3 109.605 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.416 ' CD1' ' C ' ' A' ' 141' ' ' TYR . 27.2 t80 -72.51 128.9 37.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.506 -0.746 . . . . 0.33 110.144 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.0 t -141.05 142.36 34.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.533 -0.729 . . . . 0.29 109.496 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.496 ' CE2' ' OG ' ' A' ' 108' ' ' SER . 68.7 t80 -83.22 142.7 30.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.175 -0.953 . . . . 0.31 109.377 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.5 t -140.37 153.96 46.56 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.379 -0.826 . . . . 1.0 109.894 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.82 106.0 1.7 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.976 -1.649 . . . . 0.53 108.976 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -77.05 3.52 12.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -1.122 . . . . 2.91 110.12 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.9 m -59.74 -49.23 78.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.091 -1.006 . . . . 1.71 110.298 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -132.66 23.6 4.32 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.414 -0.804 . . . . 3.55 110.137 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -65.94 129.57 40.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.946 -1.096 . . . . 0.57 110.523 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 15.7 mtm -133.06 148.58 52.2 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.906 -1.146 . . . . 2.23 107.906 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.5 mt -51.12 125.17 23.44 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.004 -1.06 . . . . 0.46 109.089 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -65.47 176.71 3.18 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 CA-C-N 120.062 1.058 . . . . 0.32 112.543 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -59.98 -39.99 87.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.442 -0.786 . . . . 1.14 109.915 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -54.6 -49.21 70.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.222 -0.924 . . . . 1.13 109.757 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -70.06 -39.98 75.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -0.955 . . . . 1.14 110.435 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.6 t -61.51 -47.88 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.013 -1.054 . . . . 0.27 109.777 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -61.08 -39.96 91.88 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.732 -1.23 . . . . 1.96 109.482 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -69.77 -54.48 12.08 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.26 -0.971 . . . . 0.22 111.267 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.446 HG23 ' N ' ' A' ' 160' ' ' GLN . 4.2 tp -60.73 -40.01 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.739 -1.448 . . . . 0.27 109.511 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.551 ' O ' ' N ' ' A' ' 164' ' ' GLY . 96.9 mt-30 -67.34 -35.17 78.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.023 -1.048 . . . . 1.88 109.469 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 87.1 p -64.91 -26.73 68.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.08 -1.013 . . . . 0.35 109.536 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 90.7 mt -89.36 -50.15 6.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.205 -0.934 . . . . 0.36 110.254 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -93.44 -9.65 37.78 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.098 -1.002 . . . . 0.43 109.975 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 160' ' ' GLN . . . . . . . . 0 N--CA 1.492 2.394 0 N-CA-C 109.563 -1.415 . . . . 1.01 109.563 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' WAY . . . . . 1.087 ' CJ ' ' HE3' ' A' ' 169' ' ' WAY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_